المؤلفون: M.W. Rohaan, R. Gomez-Eerland, J.H. van den Berg, M.H. Geukes Foppen, M. van Zon, B. Raud, I. Jedema, S. Scheij, R. de Boer, N.A.M. Bakker, D. van den Broek, L.M. Pronk, L.G. Grijpink-Ongering, A. Sari, R. Kessels, M. van den Haak, H.A. Mallo, M. Karger, B.A. van de Wiel, C.L. Zuur, C.W. Duinkerken, F. Lalezari, J.V. van Thienen, S. Wilgenhof, C.U. Blank, J.H. Beijnen, B. Nuijen, T.N. Schumacher, J.B.A.G. Haanen

المصدر: Immuno-Oncology and Technology, Vol 15, Iss , Pp 100089- (2022)

مصطلحات موضوعية: adoptive cell therapy, immunotherapy, MART-1, melanoma, T-cell receptor gene therapy, uveal, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S259001882200020X; https://doaj.org/toc/2590-0188

URL الوصول: https://doaj.org/article/6520e825ec494f5aa62686c6ff951c91

المؤلفون: J.M. Versluis, A.M. Menzies, K. Sikorska, E.A. Rozeman, R.P.M. Saw, W.J. van Houdt, H. Eriksson, W.M.C. Klop, S. Ch’ng, J.V. van Thienen, H. Mallo, M. Gonzalez, A. Torres Acosta, L.G. Grijpink-Ongering, A. van der Wal, A. Bruining, B.A. van de Wiel, R.A. Scolyer, J.B.A.G. Haanen, T.N. Schumacher, A.C.J. van Akkooi, G.V. Long, C.U. Blank

المصدر: Annals of Oncology. 34:420-430

مصطلحات موضوعية: Oncology, Hematology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::562a7244b2c0eb006ee9403d009b8d7f
https://doi.org/10.1016/j.annonc.2023.01.004

المؤلفون: E.E. Fransen van de Putte, L. Van Den Brink, M. Mansour, J.C. Van Der Mijn, S. Wilgenhof, J.V. Van Thienen, J.B.A. Haanen, E. Boleti, T. Powles, P.J. Zondervan, N.M. Graafland, A. Bex

المصدر: European Urology. 83:S475-S476

مصطلحات موضوعية: Urology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::a434b8ffa2a40287b18f6c01aa34be42
https://doi.org/10.1016/s0302-2838(23)00376-7

المؤلفون: E.A. Reijm, Sofie Wilgenhof, J.V. van Thienen, J.B.A.G. Haanen, Axel Bex

المصدر: Kidney Cancer. 3:199-211

مصطلحات موضوعية: Oncology, Nephrology, Renal cell carcinoma, business.industry, Key (cryptography), medicine, Cancer research, medicine.disease, business, Immune checkpoint

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::b487389d500d2c8e610125f904ea91e3
https://doi.org/10.3233/kca-190065

المؤلفون: B.A. van de Wiel, Charlotte L. Zuur, Serigne Lo, Michel W.J.M. Wouters, Carolien Bierman, María Jesús González González, Elena Shklovskaya, Christian U. Blank, Willem M.C. Klop, Elisa A. Rozeman, Robert V. Rawson, J.B.A.G. Haanen, Omgo E. Nieweg, James S. Wilmott, Andrew J. Spillane, Robyn P. M. Saw, J.V. van Thienen, C. Adhikari, Sydney Ch'ng, A.C.J. van Akkooi, Michael T. Tetzlaff, Hanna Eriksson, Helen Rizos, Alexander Guminski, Richard A. Scolyer, Kerwin F. Shannon, W.J. van Houdt, Jonathan R. Stretch, Georgina V. Long, A.M. Menzies

المصدر: Annals of Oncology, 32(6), 766-777. ELSEVIER

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Skin Neoplasms, medicine.medical_treatment, Ipilimumab, 03 medical and health sciences, 0302 clinical medicine, Fibrosis, Internal medicine, medicine, Humans, Melanoma, Pathological, Lymph node, business.industry, neoadjuvant, Reproducibility of Results, Hematology, Immunotherapy, medicine.disease, Neoadjuvant Therapy, 030104 developmental biology, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Biomarker (medicine), immunotherapy, Nivolumab, business, pathological response, medicine.drug, metastatic melanoma

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffb61a837c13200f2514a9ed7c1f22af
https://hdl.handle.net/1887/3276136

المؤلفون: J.V. van Thienen, E.A. Huis in ’t Veld, L. van Teeseling, I.C. van Seventer, Marianne B. Crijns

المصدر: Journal of the European Academy of Dermatology and Venereology. 34

مصطلحات موضوعية: Adult, Male, Oncology, medicine.medical_specialty, Skin Neoplasms, Metastatic melanoma, medicine.medical_treatment, Dermatology, Targeted therapy, Internal medicine, Humans, Medicine, Molecular Targeted Therapy, Melanoma, Physical Examination, Aged, Aged, 80 and over, business.industry, Skin examination, Immunotherapy, Middle Aged, Survival Analysis, Infectious Diseases, Disease Progression, Female, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::937b13c640eb22974c4938e891717afe
https://doi.org/10.1111/jdv.16128

المؤلفون: A.J. de Langen, Y.M. van der Linden, M.C. de Jong, J.V. van Thienen, E. Van Aken, Corrie A.M. Marijnen

المصدر: Radiotherapy and Oncology. 161:S1214-S1215

مصطلحات موضوعية: Oncology, Hypofractionated Radiotherapy, medicine.medical_specialty, business.industry, medicine.medical_treatment, Internal medicine, medicine, Radiology, Nuclear Medicine and imaging, Hematology, Immunotherapy, business, Targeted therapy

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::8ee6993e778caf40c9e7a77f8da90404
https://doi.org/10.1016/s0167-8140(21)07934-2

المؤلفون: J.M. Versluis, I.L.M. Reijers, E.A. Rozeman, K. Sikorska, W.J. van Houdt, J.V. van Thienen, S.A. Adriaansz, H. Mallo, H. van Tinteren, B.A. van de Wiel, L.G. Grijpink-Ongering, A. Bruining, J.B.A.G. Haanen, A.C.J. van Akkooi, T.N. Schumacher, C.U. Blank

المصدر: Annals of Oncology. 31:S742-S743

مصطلحات موضوعية: Oncology, Hematology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::6c7ea9116c5bd91864959164dc04c905
https://doi.org/10.1016/j.annonc.2020.08.1221

المؤلفون: Christian U. Blank, Hilde Rosing, J.V. van Thienen, Stefanie L. Groenland, N. de Vries, Sofie Wilgenhof, J.B.A.G. Haanen, A. D. R. Huitema, C.M. Nijenhuis, Neeltje Steeghs, Julie M Janssen, J. H. Beijnen

المصدر: Annals of Oncology. 31:S486-S487

مصطلحات موضوعية: Trametinib, Oncology, medicine.medical_specialty, business.industry, Melanoma, Dabrafenib, Hematology, medicine.disease, Internal medicine, medicine, business, Exposure response, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::9e6ccfef82f8df5ec46ce8821ee94072
https://doi.org/10.1016/j.annonc.2020.08.681

المؤلفون: A. D. R. Huitema, C.M. Nijenhuis, Hilde Rosing, Jan H.M. Schellens, J.B.A.G. Haanen, J.V. van Thienen, Jos H. Beijnen, Christian U. Blank

المصدر: The Journal of Clinical Pharmacology. 57:125-128

مصطلحات موضوعية: Pharmacology, medicine.diagnostic_test, business.industry, Melanoma, medicine.disease, 030226 pharmacology & pharmacy, Proto-Oncogene Proteins B-raf, 03 medical and health sciences, 0302 clinical medicine, Pharmacokinetics, Therapeutic drug monitoring, 030220 oncology & carcinogenesis, Mutation (genetic algorithm), Lc ms ms, medicine, Pharmacology (medical), Vemurafenib, business, Exposure response, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::c8ab4b99abf1ad17e92f10eb67d62e69
https://doi.org/10.1002/jcph.788

المؤلفون: Willem Boogerd, J.V. van Thienen, M.H. Geukes Foppen, C. Blank, Dieta Brandsma, J.B.A.G. Haanen

المصدر: Annals of Oncology. 27:1138-1142

مصطلحات موضوعية: Adult, Male, Oncology, medicine.medical_specialty, medicine.medical_treatment, Ipilimumab, survival, Targeted therapy, immune checkpoint inhibitors, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Meningeal Neoplasms, medicine, Humans, Molecular Targeted Therapy, Melanoma, leptomeningeal metastases, Aged, Netherlands, Retrospective Studies, Aged, 80 and over, business.industry, Cancer, BRAF inhibitors, Dabrafenib, Retrospective cohort study, Hematology, Immunotherapy, Middle Aged, Prognosis, medicine.disease, Surgery, 030220 oncology & carcinogenesis, Female, business, 030217 neurology & neurosurgery, Progressive disease, medicine.drug

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92c1950ae48e71aec04967442c7d1ddb
https://doi.org/10.1093/annonc/mdw134

المؤلفون: Christian U. Blank, Bernadett Szabados, M. Grant, Ekaterini Boleti, Axel Bex, Yasmin Abu-Ghanem, Thomas Powles, J.V. van Thienen, A. Meerveld-Eggink, Sofie Wilgenhof, J.B.A.G. Haanen, Niels M. Graafland

المصدر: Annals of Oncology. 31:S575

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Renal cell carcinoma, business.industry, Internal medicine, medicine, Ipilimumab, Hematology, Nivolumab, medicine.disease, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::abc38bd69f67220c2ce7cacfe6f49f83
https://doi.org/10.1016/j.annonc.2020.08.809

المؤلفون: Robert Mason, J.V. van Thienen, Henrik Schmidt, Oddbjørn Straume, Lars Bastholt, Christian U. Blank, M.H. Geukes Foppen, Simone M. Goldinger, Leena Tiainen, Marta Nyakas, Elisa A. Rozeman, Bart Neyns, Victoria Atkinson, Georgina V. Long, Inge Marie Svane, Y.J.L. Jansen, Teofila Seremet, A. Arance, Lise Hoejberg, Alexander M. Menzies, J.B.A.G. Haanen, Siru Mäkelä, Reinhard Dummer

المساهمون: Surgery, Faculty of Medicine and Pharmacy, Clinical sciences, Medical Oncology, Laboratory for Medical and Molecular Oncology, Laboratory of Molecullar and Cellular Therapy, HUS Comprehensive Cancer Center, Department of Oncology, University of Helsinki, University of Zurich, Jansen, Y J L

المصدر: Jansen, Y J L, Rozeman, E A, Mason, R, Goldinger, S M, Geukes Foppen, M H, Højberg, L, Schmidt, H, van Thienen, J V, Haanen, J B A G, Tiainen, L, Svane, I M, Mäkelä, S, Seremet, T, Arance, A, Dummer, R, Bastholt, L, Nyakas, M, Straume, O, Menzies, A M, Long, G V, Atkinson, V, Blank, C U & Neyns, B 2019, ' Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity : clinical outcomes in advanced melanoma ', Annals of Oncology, vol. 30, no. 7, pp. 1154-1161 . https://doi.org/10.1093/annonc/mdz110
Jansen, Y J L, Rozeman, E A, Mason, R, Goldinger, S M, Geukes Foppen, M H, Hoejberg, L, Schmidt, H, Van Thienen, J V, Haanen, J B A G, Tiainen, L, Svane, I M, Mäkelä, S, Seremet, T, Arance, A, Dummer, R, Bastholt, L, Nyakas, M, Straume, O, Menzies, A M, Long, G V, Atkinson, V, Blank, C U & Neyns, B 2019, ' Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity : clinical outcomes in advanced melanoma ', Annals of Oncology, vol. 30, no. 7, mdz110, pp. 1154-1161 . https://doi.org/10.1093/annonc/mdz110
Jansen, Y J L, Rozeman, E A, Mason, R, Goldinger, S M, Geukes Foppen, M H, Hoejberg, L, Schmidt, H, Van Thienen, J V, Haanen, J B A G, Tiainen, L, Svane, I M, Mäkelä, S, Seremet, T, Arance, A, Dummer, R, Bastholt, L, Nyakas, M, Straume, O, Menzies, A M, Long, G V, Atkinson, V, Blank, C U & Neyns, B 2019, ' Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity : clinical outcomes in advanced melanoma ', Annals of Oncology, vol. 30, no. 7, pp. 1154-1161 . https://doi.org/10.1093/annonc/mdz110

مصطلحات موضوعية: Male, 0301 basic medicine, Skin Neoplasms, Programmed Cell Death 1 Receptor, 2720 Hematology, MONOTHERAPY, Pembrolizumab, Gastroenterology, Cohort Studies, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Prospective Studies, Aged, 80 and over, anti-PD-1 therapy, 10177 Dermatology Clinic, Hematology, Middle Aged, Evaluable Disease, Prognosis, Substance Withdrawal Syndrome, 3. Good health, Survival Rate, Nivolumab, Oncology, SAFETY, 030220 oncology & carcinogenesis, Cohort, Disease Progression, SURVIVAL, Female, 2730 Oncology, immunotherapy, duration of treatment, Cohort study, medicine.drug, Adult, medicine.medical_specialty, 3122 Cancers, 610 Medicine & health, Ipilimumab, Antibodies, Monoclonal, Humanized, PROFILE, 03 medical and health sciences, Internal medicine, melanoma, medicine, Humans, PEMBROLIZUMAB, Aged, Retrospective Studies, business.industry, IPILIMUMAB, Discontinuation, Clinical trial, 030104 developmental biology, COMBINED NIVOLUMAB, business, Follow-Up Studies

وصف الملف: application/pdf; 811_Jansen_Y._et_al._Discontinuation_of_anti-PD-1_antibody_therapy_in_the_absence_of_disease_progression_or_treatment_limiting_toxicity_etc._Annals_of_Oncology_2019.pdf - application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acb2426cfdad8323d67c5bd20e80a59e
https://curis.ku.dk/portal/da/publications/discontinuation-of-antipd1-antibody-therapy-in-the-absence-of-disease-progression-or-treatment-limiting-toxicity(00dd1bed-a3b3-45b5-b8d4-f911468c6499).html

المؤلفون: Christian U. Blank, Sofie Wilgenhof, J.B.A.G. Haanen, Loes M. Pronk, Maartje W. Rohaan, J.H. van den Berg, B.A. van de Wiel, T.N. Schumacher, A. Sari, Ferry Lalezari, H. van Tinteren, Raquel Gomez-Eerland, H. Mallo, M. van Zon, Bastiaan Nuijen, J.V. van Thienen, M.H. Geukes Foppen, J. H. Beijnen, R. De Boer, Noor A. M. Bakker

المصدر: Annals of Oncology. 30:v481-v482

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Metastatic melanoma, business.industry, Stock options, Melan-A Protein, Hematology, Peripheral blood, Autologous T-cells, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Oncology, Cell dose, 030220 oncology & carcinogenesis, Maximum tolerated dose, Internal medicine, medicine, In patient, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::9b3374e4370635ab1a9b126103cb46e1
https://doi.org/10.1093/annonc/mdz253.010

المؤلفون: H. van Tinteren, J.B.A.G. Haanen, Christian U. Blank, A. Scholtens, J.V. van Thienen, M.H. Geukes Foppen

المصدر: European Journal of Cancer. 51:642-652

مصطلحات موضوعية: Adult, Male, Proto-Oncogene Proteins B-raf, Oncology, Cancer Research, medicine.medical_specialty, Indoles, Skin Neoplasms, Time Factors, Kaplan-Meier Estimate, Disease-Free Survival, Drug Administration Schedule, Risk Factors, Internal medicine, Humans, Medicine, Vemurafenib, Melanoma, Protein Kinase Inhibitors, Aged, Netherlands, Proportional Hazards Models, Retrospective Studies, Response rate (survey), Sulfonamides, business.industry, Standard treatment, Hazard ratio, Retrospective cohort study, Dabrafenib, Middle Aged, medicine.disease, Treatment Outcome, Multivariate Analysis, Mutation, Cutaneous melanoma, Immunology, Disease Progression, Female, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09fe2cb4cae628f7cac178c9d319b2d9
https://doi.org/10.1016/j.ejca.2015.01.009

المؤلفون: B.A. van de Wiel, Elisa A. Rozeman, Sandra Adriaansz, A.C.J. van Akkooi, Christian U. Blank, W.J. van Houdt, J.B.A.G. Haanen, Judith M. Versluis, H. van Tinteren, Irene L.M. Reijers, Lindsay G Grijpink-Ongering, Karolina Sikorska, Annemarie Bruining, T.N. Schumacher, H. Mallo, J.V. van Thienen

المصدر: Annals of Oncology. 30:v535

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, business.industry, Immune checkpoint inhibitors, Ipilimumab, Hematology, Neo adjuvant, Long term toxicity, Relapse free survival, Clinical trial, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Oncology, 030220 oncology & carcinogenesis, Family medicine, medicine, Stage III melanoma, Nivolumab, business, health care economics and organizations, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::553fb723c3cfe0a8e6656865e9e75cfc
https://doi.org/10.1093/annonc/mdz255.003

المؤلفون: Christian U. Blank, Sofie Wilgenhof, H. Van Rossum, J.B.A.G. Haanen, J.V. van Thienen, M. van den Heuvel, Elisa A. Rozeman, R. Moritz

المصدر: Annals of Oncology. 30:v553

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, business.industry, Anti pd 1, Hematology, Predictive value, Clinical Practice, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Oncology, 030220 oncology & carcinogenesis, Visual accommodation, Family medicine, Early prediction, medicine, Retrospective analysis, S100b protein, business, Advanced melanoma

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::e0d1ce06fcda25bd8cfb108d221d690d
https://doi.org/10.1093/annonc/mdz255.044

المؤلفون: Loes M. Pronk, B.A. van de Wiel, Sofie Wilgenhof, J.V. van Thienen, J. Lijnsvelt, Karolina Sikorska, A. Sari, W. Uyterlinde, J.B.A.G. Haanen, C. Blank, H. Mallo, M.A. Vollenbergh, Lindsay G Grijpink-Ongering, Elisa A. Rozeman, Sandra Adriaansz, J.W.B. de Groot, Birthe Heeres

المصدر: Annals of Oncology. 29:viii736

مصطلحات موضوعية: 0301 basic medicine, MAPK/ERK pathway, business.industry, Phases of clinical research, Hematology, Pembrolizumab, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Oncology, 030220 oncology & carcinogenesis, Mutation (genetic algorithm), Cancer research, Medicine, In patient, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::e4b52c8d907b740e95c2ab9bf2ad75b7
https://doi.org/10.1093/annonc/mdy424.056

المؤلفون: J.B.A.G. Haanen, J. Lijnsvelt, C. Blank, W. Uyterlinde, Sandra Adriaansz, Sofie Wilgenhof, J.V. van Thienen, Irene L.M. Reijers, Elisa A. Rozeman, H. Mallo

المصدر: Annals of Oncology. 29:viii449

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, business.industry, Immune checkpoint inhibitors, Melanoma, medicine.medical_treatment, Hematology, medicine.disease, Targeted therapy, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, Retrospective analysis, Medicine, business

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::100a0418368b10111c607c6a1979f00b
https://doi.org/10.1093/annonc/mdy289.015

المؤلفون: Christian U. Blank, Marco Donia, Bastiaan Nuijen, J.H. van den Berg, J.V. van Thienen, R. De Boer, A.C.J. van Akkooi, Maartje W. Rohaan, M.H. Geukes Foppen, T.H. Borch, Loes M. Pronk, Sofie Wilgenhof, J.B.A.G. Haanen, Özcan Met, M. van Zon, E.A.M. Bakker, Inge Marie Svane

المساهمون: Academic Medical Center

المصدر: Annals of oncology, 29. Oxford University Press

مصطلحات موضوعية: Chemotherapy, Metastatic melanoma, Tumor-infiltrating lymphocytes, business.industry, Lymphocyte, medicine.medical_treatment, Non myeloablative, Ipilimumab, Hematology, Interleukine 2, Regimen, medicine.anatomical_structure, Oncology, medicine, Cancer research, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abb0fcd209bf848e28b9252a150a27c6
https://doi.org/10.1093/annonc/mdy289.059